" the nail flows " in our country The vaccine clinical trial makes good progress

" the nail flows " in our country The vaccine clinical trial makes good progress
" the nail flows " in our country The vaccine clinical trial makes good progress
It is reported ' The people Yue, king of reporter, outstanding to loose in Yang) The clinical experiment work of first type H1N1 influenza vaccine of our country makes good progress. After finishing inoculating the preliminary security analysis report of the first injection first type H1N1 influenza vaccine to experimenters, since August 12, first type H1N1 influenza vaccine clinical trial experimenters have begun to inoculate the second stitch, the whole clinical trial is expected to finish in mid-September. It is reported, our country has first type H1N1 influenza vaccine which a vaccine manufacturing enterprise of 10 of influenza produces to enter the clinical trial at present, experimenters reach more than 13300 people. In the clinical trial after the first stitch of first type H1N1 influenza vaccine inoculates is observed safely, have not found serious bad reaction or incident. The following preliminary security analysis report reveals too, it is safe and reliable for the first type H1N1 influenza test that our country produces to use vaccine. First type H1N1 influenza vaccine of our country begins the clinical trial in July, all clinical trials are carried on under the guidance of Center for Disease Prevention and Control of China. Director of Chinese Center for Disease Prevention and Control Wang Yu introduces, in order to guarantee first type H1N1 influenza vaccine clinical trial science, in order, the security goes on, Center for Disease Prevention and Control of China has specially made " The first type H1N1 influenza vaccine clinical trial guides the scheme " ,In order to guide each clinical test unit and clinical research for producing enterprise of vaccine. Wang Yu introduces, after experimenters inoculate the second stitch, the expert panel of Ministry of Public Health will study and judge the security of first type H1N1 influenza vaccine of our country tentatively in mid-August, our country's whole first type H1N1 influenza vaccine clinical research is expected to finish in September. When the time comes, Ministry of Public Health will confirm immunizing tactics and scheme of vaccine according to latest progress of the epidemic situation. At present, Ministry of Public Health is sustaining, paying close attention to the development of the first type H1N1 influenza epidemic situation of our country, and follow vaccine researching and developing and operating position of World Health Organization and each country at any time, develop and adjust using the tactics of vaccine at any time according to the epidemic situation. The research and development of first type H1N1 influenza vaccine of our country is in pace with world, the reason why enter clinical trial stage smoothly in a short period of time, lie in close unity and cooperation in respects such as the government, enterprise, technology research and development organization, medical unit,etc.. The improvement of integral level and ability that this pair of vaccine of our country researches and develops has demonstrating and facilitation. Wang Yu introduces, primary principle observed in research and development of first type H1N1 influenza vaccine of our country is " safe " . Not merely follow science, orderly, safe tactics in the clinical trial, after the clinical trial finishes, the related departments will pay close attention to the fact continuously too the production, clinic of first type H1N1 influenza vaccine will be used safely that hygiene, medicine supervise,etc..


|